肝癌介入治疗后患者心理痛苦耐受现状及影响因素分析

IF 0.5 4区 医学 Q4 PHARMACOLOGY & PHARMACY Psychiatry and Clinical Psychopharmacology Pub Date : 2024-12-17 DOI:10.5152/pcp.2024.24956
Li Yang, Liuyin Zhou, Chaofu Zhao, Lingdan Lan, Chao Ji, Jianfei Tu, Weidan Xu
{"title":"肝癌介入治疗后患者心理痛苦耐受现状及影响因素分析","authors":"Li Yang, Liuyin Zhou, Chaofu Zhao, Lingdan Lan, Chao Ji, Jianfei Tu, Weidan Xu","doi":"10.5152/pcp.2024.24956","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Interventional therapy, currently, has become a major method for the clinical treatment of liver cancer patients. However, interventional therapy can also lead to various toxic side effects, and combined with the impact of the disease itself, liver cancer patients often experience more severe emotional distress. Improving individuals' levels of psychological distress tolerance may reduce sensitivity to negative life events and experiences. At this stage, there is no relevant literature reporting on the psychological distress tolerance of liver cancer patients after interventional therapy. This study investigates and analyzes psychological distress tolerance in liver cancer patients after interventional therapy, aiming to optimize personalized nursing interventions and improve patients' long-term quality of life.</p><p><strong>Methods: </strong>This study is a cross-sectional study. Convenience sampling is adopted. Liver cancer patients who underwent interventional therapy in our hospital from August 2023 to May 2024 were selected. General Information Questionnaire, Psychological Distress Tolerance Scale, Psychological Resilience Scale, Fear of Progression Questionnaire-Short Form, and Perceived Social Support Scale were used for data collection. Multiple linear regression analysis was performed to identify the influencing factors of psychological distress tolerance in liver cancer patients after interventional therapy.</p><p><strong>Results: </strong>The total score of psychological distress tolerance in 157 liver cancer patients was 26.88 ± 4.15, with item scores for each dimension ranging from low to high, namely, pain endurance and pain management. The results of multiple linear regression analysis showed that age, tumor size, number of tumors, psychological resilience, fear of disease progression, and perceived social support were influencing factors of psychological distress tolerance in liver cancer patients after interventional therapy (P < .05).</p><p><strong>Conclusion: </strong>The level of psychological distress tolerance in liver cancer patients after interventional therapy needs to be improved, and it is relevant to age, tumor size, number of tumors, psychological resilience, fear of disease progression, and perceived social support.</p>","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"34 4","pages":"342-348"},"PeriodicalIF":0.5000,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744382/pdf/","citationCount":"0","resultStr":"{\"title\":\"Analysis of Current Status and Influencing Factors of Psychological Distress Tolerance in Liver Cancer Patients after Interventional Therapy.\",\"authors\":\"Li Yang, Liuyin Zhou, Chaofu Zhao, Lingdan Lan, Chao Ji, Jianfei Tu, Weidan Xu\",\"doi\":\"10.5152/pcp.2024.24956\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Interventional therapy, currently, has become a major method for the clinical treatment of liver cancer patients. However, interventional therapy can also lead to various toxic side effects, and combined with the impact of the disease itself, liver cancer patients often experience more severe emotional distress. Improving individuals' levels of psychological distress tolerance may reduce sensitivity to negative life events and experiences. At this stage, there is no relevant literature reporting on the psychological distress tolerance of liver cancer patients after interventional therapy. This study investigates and analyzes psychological distress tolerance in liver cancer patients after interventional therapy, aiming to optimize personalized nursing interventions and improve patients' long-term quality of life.</p><p><strong>Methods: </strong>This study is a cross-sectional study. Convenience sampling is adopted. Liver cancer patients who underwent interventional therapy in our hospital from August 2023 to May 2024 were selected. General Information Questionnaire, Psychological Distress Tolerance Scale, Psychological Resilience Scale, Fear of Progression Questionnaire-Short Form, and Perceived Social Support Scale were used for data collection. Multiple linear regression analysis was performed to identify the influencing factors of psychological distress tolerance in liver cancer patients after interventional therapy.</p><p><strong>Results: </strong>The total score of psychological distress tolerance in 157 liver cancer patients was 26.88 ± 4.15, with item scores for each dimension ranging from low to high, namely, pain endurance and pain management. The results of multiple linear regression analysis showed that age, tumor size, number of tumors, psychological resilience, fear of disease progression, and perceived social support were influencing factors of psychological distress tolerance in liver cancer patients after interventional therapy (P < .05).</p><p><strong>Conclusion: </strong>The level of psychological distress tolerance in liver cancer patients after interventional therapy needs to be improved, and it is relevant to age, tumor size, number of tumors, psychological resilience, fear of disease progression, and perceived social support.</p>\",\"PeriodicalId\":20847,\"journal\":{\"name\":\"Psychiatry and Clinical Psychopharmacology\",\"volume\":\"34 4\",\"pages\":\"342-348\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2024-12-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744382/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychiatry and Clinical Psychopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5152/pcp.2024.24956\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry and Clinical Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5152/pcp.2024.24956","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:介入治疗目前已成为临床治疗肝癌患者的主要方法。然而,介入治疗也会导致各种毒副作用,再加上疾病本身的影响,肝癌患者往往会经历更严重的情绪困扰。提高个体的心理痛苦耐受水平可以降低对负面生活事件和经历的敏感性。现阶段尚无相关文献报道肝癌患者介入治疗后的心理困扰耐受性。本研究调查分析肝癌患者介入治疗后的心理痛苦耐受性,旨在优化个性化护理干预,提高患者的长期生活质量。方法:本研究为横断面研究。采用方便抽样。选择2023年8月至2024年5月在我院行介入治疗的肝癌患者。采用一般信息问卷、心理困扰耐受量表、心理弹性量表、进度恐惧简易问卷和感知社会支持量表进行数据收集。采用多元线性回归分析肝癌患者介入治疗后心理困扰耐受性的影响因素。结果:157例肝癌患者心理痛苦耐受总分为26.88±4.15分,各维度项目得分由低到高,分别为疼痛耐受和疼痛管理。多元线性回归分析结果显示,年龄、肿瘤大小、肿瘤数量、心理弹性、对疾病进展的恐惧、感知社会支持是肝癌患者介入治疗后心理痛苦耐受的影响因素(P < 0.05)。结论:肝癌患者介入治疗后的心理痛苦耐受水平有待提高,其与年龄、肿瘤大小、肿瘤数量、心理弹性、对疾病进展的恐惧、感知到的社会支持等因素有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Analysis of Current Status and Influencing Factors of Psychological Distress Tolerance in Liver Cancer Patients after Interventional Therapy.

Background: Interventional therapy, currently, has become a major method for the clinical treatment of liver cancer patients. However, interventional therapy can also lead to various toxic side effects, and combined with the impact of the disease itself, liver cancer patients often experience more severe emotional distress. Improving individuals' levels of psychological distress tolerance may reduce sensitivity to negative life events and experiences. At this stage, there is no relevant literature reporting on the psychological distress tolerance of liver cancer patients after interventional therapy. This study investigates and analyzes psychological distress tolerance in liver cancer patients after interventional therapy, aiming to optimize personalized nursing interventions and improve patients' long-term quality of life.

Methods: This study is a cross-sectional study. Convenience sampling is adopted. Liver cancer patients who underwent interventional therapy in our hospital from August 2023 to May 2024 were selected. General Information Questionnaire, Psychological Distress Tolerance Scale, Psychological Resilience Scale, Fear of Progression Questionnaire-Short Form, and Perceived Social Support Scale were used for data collection. Multiple linear regression analysis was performed to identify the influencing factors of psychological distress tolerance in liver cancer patients after interventional therapy.

Results: The total score of psychological distress tolerance in 157 liver cancer patients was 26.88 ± 4.15, with item scores for each dimension ranging from low to high, namely, pain endurance and pain management. The results of multiple linear regression analysis showed that age, tumor size, number of tumors, psychological resilience, fear of disease progression, and perceived social support were influencing factors of psychological distress tolerance in liver cancer patients after interventional therapy (P < .05).

Conclusion: The level of psychological distress tolerance in liver cancer patients after interventional therapy needs to be improved, and it is relevant to age, tumor size, number of tumors, psychological resilience, fear of disease progression, and perceived social support.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Psychiatry and Clinical Psychopharmacology
Psychiatry and Clinical Psychopharmacology Medicine-Psychiatry and Mental Health
CiteScore
1.00
自引率
14.30%
发文量
0
期刊介绍: Psychiatry and Clinical Psychopharmacology aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology publishes high quality research targeted to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related sciences.
期刊最新文献
A Study on Gambling Behavior in Türkiye: Perceptions, Attitudes, Thoughts, and Behaviors Toward Gambling. Analysis of Current Status and Influencing Factors of Psychological Distress Tolerance in Liver Cancer Patients after Interventional Therapy. Differential Expression of miR-26b-5p, EGR1, and STAT1 in Peripheral Blood of Schizophrenia Patients. Effects of Acceptance and Commitment Care in the Treatment of Aplastic Anemia Patients with Recombinant Human Thrombopoietin. Evaluating Body Image Disturbance and Its Influencing Factors in Breast Cancer Patients Following Unilateral Mastectomy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1